Heron Therapeutics Inc vs OneSpan Inc — how do they compare? Heron Therapeutics Inc trades at $0.46 (market cap $91.46M), while OneSpan Inc trades at $15.37 (market cap $575.37M). The key difference: OneSpan Inc is far larger — about 6.3× Heron Therapeutics Inc's market cap, and OneSpan Inc pays a 3.35% dividend while Heron Therapeutics Inc pays none. Which is the better fit depends on your goals.
| HRTX | OSPN | |
|---|---|---|
Market Cap | $91.46M | $575.37M |
Sector | Health | Technology |
52-Week High | $1.96 | $16.32 |
52-Week Low | $0.39 | $10.15 |
Enterprise Value | $189.36M | $533.57M |
Dividend Yield | — | 3.35% |
Trailing returns across standard periods
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →OneSpan Inc. is a global leader in providing digital agreement security solutions. The company's platform helps organizations, primarily in the financial services sector, to secure their digital agreements and transactions, including e-signatures, multi-factor authentication, and transaction monitoring. OneSpan's technology is focused on protecting customers from fraud and meeting regulatory compliance requirements in a digital-first environment.
Read more on OSPN →